Financials

News Discussions Technicals Forecast Seasonals

Enterprise value of Tarsus Pharmaceuticals, Inc.

Annual data

2019

2020

2021

2022

2023

2024

‪0.00‬

‪‪500.00 M‬‬

‪‪1.00 B‬‬

‪‪1.50 B‬‬

‪‪2.00 B‬‬

Period

Value

Change

Change %

2024

‪‪1.86 B‬‬

+‪‪1.46 B‬‬

+‪366.63‬%

2023

‪‪399.30 M‬‬

+‪‪235.19 M‬‬

+‪143.32‬%

2022

‪‪164.11 M‬‬

‪‪−127.74 M‬‬

‪−43.77‬%

2021

‪‪291.85 M‬‬

‪‪−380.79 M‬‬

‪−56.61‬%

2020

‪‪672.64 M‬‬

—

—

2019

Quarterly data

Q1 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪‪260.00 M‬‬

‪‪520.00 M‬‬

‪‪780.00 M‬‬

‪‪1.04 B‬‬

Period

Value

Change

Change %

Q4 '24

—

—

—

Q3 '24

‪‪1.02 B‬‬

+‪‪241.13 M‬‬

+‪31.05‬%

Q2 '24

‪‪776.64 M‬‬

‪‪−238.53 M‬‬

‪−23.50‬%

Q1 '24

‪‪1.02 B‬‬

+‪‪564.01 M‬‬

+‪125.01‬%

Q4 '23

‪‪451.16 M‬‬

+‪‪123.75 M‬‬

+‪37.80‬%

Q3 '23

‪‪327.41 M‬‬

‪‪−3.96 M‬‬

‪−1.20‬%

Q2 '23

‪‪331.37 M‬‬

+‪‪171.22 M‬‬

+‪106.92‬%

Q1 '23

‪‪160.15 M‬‬

‪‪−34.86 M‬‬

‪−17.88‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q1 '20